Rapid Dose Therapeutics Corp.

Play Interview



Commenced Trading

December 17 2018

Primary Exchange/Symbol


Listing By Way Of


Shares Issued, Outstanding


Investor Information

Mark Upsdell, CEO is results-driven and focused leader with proven success in new market identification and strategic positioning. Proven track record of increasing sales while establishing strategic alliances. 416-477-1052, info@rapid-dose.com

Nature Of The business

Rapid Dose Therapeutics Corp. (DOSE:CSE) is a Canadian bio-technology company providing proprietary drug delivery technologies to the pharmaceutical and healthcare manufacturing industries. Rapid Dose has three divisions and has produced a number of proprietary drug delivery technologies including QuickStrip™ which Rapid Dose management believes will take oral cannabis delivery to the next level and is now lining up partners. Mark Upsdell joins host Jim Ripley.